In a pivotal year, which saw Reata Pharmaceuticals halt research for a kidney disease treatment and receive FDA approval for its first-to-market degenerative disease treatment, the company welcomes Dr. Rajiv Patni as Chief R&D Officer. Patni marks this as an "inflection point to become a global, commercial-stage company with an expanding pipeline in both rare and common serious diseases."
Citywave standing wave technology was used for this Surf & Style European Championship event. [Photo: Urban Entertainment Concepts / PR Newswire]
The UNT Health Science Center at Fort Worth’s Sparkyard platform recently completed an online economic dashboard of Tarrant County entrepreneurial activity and two other website updates funded by a U.S....
The NBA is one of the organizations partnering with Cosm for immersive presentations of live events. [Image: NBA/Cosm]